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Aim: The status of outpatient irrational prescription drug use before and after pharmacist interventions in 6 large scale hospitals was
investigated to determine the underlying reasons and to promote rational clinical drug use.
Materials and methods: The 5-step DMAIC method (define, measure, analyze, improve, control) in Six Sigma management was utilized
to investigate irrational drug use in prescriptions. The statistical software package SAS9.1.3 was adopted to analyze the results, determine
possible reasons that could lead to irrational drug use, and then intervene accordingly. Statistics before and after the intervention were
compared to analyze the function and effect of Six Sigma management in rational drug use via pharmacist intervention.
Results: Irrational drug use rates (defect rates) before and after the intervention were 8.56% and 4.46% (P < 0.001), the Z value increased
from 2.82 to 3.01, and the differences were significant.
Conclusion: Six Sigma management will be able to computerize and refine hospital management, thereby ultimately improving service
quality.
Key words: Six Sigma management, outpatient prescription, pharmacist intervention, rational drug use

1. Introduction
The World Health Organization (WHO) defines rational
drug use as follows: drugs should be appropriate for the
clinical needs of patients, the medicine dosage should
meet their individual requirements, the treatment course
should be appropriate, and drug prices should be as low as
possible for patients and their communities (1). However,
the WHO also reports that approximately 30% of patients
worldwide die from irrational drug use rather than from
the diseases themselves. Irrational drug use delays disease
treatment, wastes medical resources, results in adverse
drug reactions and drug-induced diseases, and even leads
to medical incidents (2–4). Irrational drug use has become
a serious problem throughout the world that cannot be
ignored, and thus it is imperative to utilize appropriate
measures to improve rational drug use levels in the medical
institutions in China (5).
Meanwhile, the Chinese government aims to further
reinforce the clinical application and management of
* Correspondence: wang_yi237@163.com
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antibiotics in medical institutions, promote the rational
use of antibiotics, effectively control bacterial resistance,
and ensure the quality and safety of medical care. To
these ends, the Chinese Ministry of Health established
the “Specific rectification program for clinical use of
antibiotics in 2011”, which was implemented nationwide
in July 2011. As a result, the clinical use and management
of antibiotics were further reinforced, the clinical use
structure of antibiotics was optimized, the clinical drug
use level of antibiotics was improved, the clinical use of
antibiotics was standardized, and bacterial resistance was
effectively suppressed. The outstanding problems therein
will be thoroughly solved, which will improve the effective
and long-term clinical use of antibiotics as well as facilitate
continuous improvement in the future (6,7).
Thus, our department combined Six Sigma
management with the program mentioned above to
manage clinical drug use through pharmacist intervention,
and satisfactory results were obtained (8).
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2. Materials and methods
2.1. Sources of statistics
Before the intervention, 18,000 outpatient prescriptions
from July to December of 2010 (500 prescriptions
per month) were randomly selected in 6 hospitals.
Illegible handwriting prescriptions were removed, and
the remaining 15,228 prescriptions were included in
this study. After the intervention, the same number of
outpatient prescriptions from July to December of 2011
were randomly selected, including 17,049 completed
prescriptions. The statistics were integral, truthful, and
reliable.
2.2. Research methods
The 5-step DMAIC method (define, measure, analyze,
improve, control) in Six Sigma management was utilized
herein, which was cooperatively carried out by the staff
in the Outpatient Pharmacy, the Clinical Pharmaceutical
Personnel and Drug Storehouse in the Department of
Pharmacy, Medical Affairs, the Information Center, the
Evidence-Based Medicine Department, and the Clinical
Department in 6 hospitals. The statistical software package
SAS9.1.3, brainstorming, and fishbone diagrams were
employed (9).
2.2.1. Define
The Six Sigma project team was set up by training the entire
staff of the Pharmacy Department in drug instructions,
the “Drug Use Notice”, “Prescription Management
Methods”, “Clinical Antibiotics Guidelines”, “New
Pharmaceutics (16th edition)”, “Hospital Prescription
Review Management Practices (Trial)”, and “Clinical
Disease Diagnosis and Treatment Guidelines”, which were
utilized to evaluate rational drug use (10–13). Irrational
prescriptions (defects) were defined as irrational aspects
discovered by project leaders that related clinicians
and pharmacists did not discern, mainly including
inappropriate indication, drug selection, drug formulation,
administration route, usage and dosage (inappropriate

administration frequency, solvent selection, dosage,
and administration time), drug combination, repeated
administration, incompatibility, adverse interactions, and
medication contraindications. A total of 11 items were
tested, each of which was determined to be an irrational
use criterion, i.e. a defect. Repeated irrational drug use
of one prescription was determined to be one irrational
number (defect number). The irrational drug use (defect)
examination form was designed before the prescription
investigation, yielding the total irrational drug use number
(total defect number) (14). Each prescription was utilized
as a unit, and the defect opportunity number was equal
to the unit number multiplied by the total defect item
number. The defect examination form for prescriptions is
presented in Table 1.
2.2.2. Measure
Five hundred prescriptions per month from July to
December in 2010 were randomly selected in each
hospital. Some paper prescriptions suffered from illegible
handwriting and missing items. Thus, incomplete
prescriptions were removed, and a total of 15,228
prescriptions were incorporated. The total number of
prescriptions and the number of irrational drug uses
(defect number) were recorded, and the irrational drug
use (defect) examination form was filled out. The resulting
statistics were collected, and the results are summarized
in Table 2. A total of 14,342 defect points were detected
based on the following equation: irrational number per
1,000,000 opportunities (defect number) = total irrational
number (defect number) at each check point/(irrational
number per unit × total unit number) × 106. The irrational
item number per unit was 11. The total unit number, i.e.
the total number of sampled prescriptions, was 15,228.
The irrational number (defect number) per 1,000,000
opportunities = 14,342/(11 × 15,228) × 106 = 85,619.79,
and the defect rate was 8.56%. The statistical software
package Minitab15 was utilized to calculate the process
capability Z value as 2.82.

Table 1. Irrational drug use (defect) examination.
Defect item
Inappropriate indication
Inappropriate drug selection
Inappropriate drug formulation and administration route
Inappropriate administration frequency
Inappropriate solvent selection
Inappropriate dosage
Inappropriate administration time
Inappropriate drug combination
With incompatibility and adverse interaction
Medication contraindication

Defect attribution and number
An irrational drug = a defect point
An irrational drug = a defect point
An irrational drug = a defect point
An irrational drug = a defect point
An irrational drug = a defect point
An irrational drug = a defect point
An irrational drug = a defect point
An irrational drug combination = a defect point
An incompatibility or an adverse interaction = a defect point
A medication contraindication = a defect point
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Table 2. Classification statistics of irrational drug use before and after the intervention.
Irrational (defect) item
Irrational indication
Irrational drug selection
Irrational drug formulation and
administration route
Irrational usage and dosage
Irrational administration frequency
Irrational solvent selection
Irrational dosage
Irrational administration time
Irrational drug combination
Repeated administration
With incompatibility and adverse interaction
Medication contraindication
Sum
Irrational (defect) rate (%)
Z value

Irrational (defect) number
before intervention

Reduced irrational
(defect) number

699
2023

Irrational (defect) number
after intervention
487
1875

414

78

336

4687
657
4168
425
598
258
344
69
14,342
8.56
2.82

3024
107
2177
116
313
62
75
43
8357
4.46
3.01

1663
550
1991
309
285
196
269
26
5985
4.10
–0.19

As shown in Table 2, irrational administration
frequency, at 4687, was the most significant item, followed
by irrational administration dosage at 4168.
2.2.3. Analyze
All the staff were convened for brainstorming, which
was combined with the statistical results of prescriptions
and rational drug use questionnaires administered to
clinicians, nurses, and patients. The main reasons leading
to irrational drug use were determined in order to plot a
fishbone diagram (Figure) for analysis (15).
2.2.4. Improve
This stage aims to ensure that the proposed method can
meet or exceed the target. Solutions were found for the
causes of irrational drug use listed in the fishbone diagram.
The same basic measures were utilized by each hospital,
which are summarized as follows.
Hospital websites, billboards, knowledge competitions,
etc., were utilized to inform and train the staff in the
guidelines mentioned in the Section “Define”. Lectures
and training sessions concerning rational drug use were
also conducted regularly. A series of measures, including
a rational drug use management system, a clinical
use and monitoring system for antibiotics, preventive
use principles for perioperative antibiotics, a warning
system for abnormal antibiotics, elimination of the
successive top 10 clinicians who prescribed antibiotics,
and hospital prescription review management practices,
were implemented to clarify the authorities of all-level
clinicians for a variety of antibiotics for prevention and
treatment (16,17).
Administration route and time were also regulated in
detail. A basic hospital medication catalog, a hospital drug
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formulary, and a hospital drug specification summary.
were developed. Drug communications were published
regularly to inform the medical staff of the latest drug
information, drug policies, laws, and regulations (18).
Medical ethics education was carried out to make the
medical staff fully aware of the importance of emotional,
humane, and psychological services, which will enhance
their responsibility and commitment to acquire the trust
and understanding of patients and to establish a good
rapport with them.
A prescription intervention and review group consisting
of multi-disciplinary experts was set up to randomly
check the outpatient prescriptions monthly and post the
results on hospital websites. Prescription review results
were included in the performance appraisal and annual
assessment of the relevant departments and staff therein.
Clinicians who had prescribed irrational prescriptions
more than once without compelling reasons were warned
and their authority restricted. More than one subsequent
abnormal prescription would lead to cancellation of the
clinician’s prescribing authority. In addition, clinicians
who failed computer operation tests were deprived of their
prescribing authority. Each instance of irrational drug use
owing to improper computer operations (dosage errors,
incorrect typing of oral and external drugs instead of
intravenous injection and oral drugs, etc.) was punished
monetarily. The hospital information system (HIS) was
continuously improved: special drug usages (e.g., blood
purification, skin tests, preprandial and postprandial
drugs) were added to the usage option (19). Meanwhile,
doctor input function was also added to enhance the
flexibility of the program. Infusion prescriptions were
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Pharmacist
Careless 
prescription review 

Clinician
Poor medical treatment 
Insufficient 
medicine knowledge
Improper drug combination 

Unprofessional operation 
Inertial thinking 

Unpersonalized administration 
Poor prescription normalization 

Irrational procedure 
Non-standard operation 

Do not follow 
doctors’ advice
Poor responsibility 
Irrational drug use 
Nurse

Lack of effective 
communication

Patient

Lack of prescription review 
and evaluation standards
Excessive drug types
Lack of updated 
drug information 
Others

Figure. A fishbone diagram that represents the reasons for irrational drug use.

normalized such that they are to be prescribed according
to the actual administration groups for the convenient
review of pharmacists.
All departments were assigned adverse drug reaction
liaisons who were trained regularly and were responsible
for monitoring, submitting, and reporting adverse drug
reactions in their own departments.
The Nursing Department cooperatively counted and
summarized the common dosage, usage, incompatibility,
and other factors of common drugs in each department.
Nurses who were aware of the distributed summarizations
were tested, and those found to be unqualified were
punished monetarily and required to participate in
supplementary examinations.
On the basis of the actual situation, the functions
of clinical pharmacists were defined as servicing
and consulting. On one hand, pharmacists should
provide clinical references for pharmacokinetics,
pharmacoeconomics,
spharmacoepidemiology,
pharmaceutics, adverse drug reactions, and drug
interactions on a weekly basis, and they should also report
the clinical treatment requirements in a timely fashion.
On the other hand, medication consultation services were
specifically set up in the outpatient pharmacy to receive
outpatient medication consultations and guide the patients
with rational drug use information (20,21).
Abnormal sales of drugs were monitored in time
by reporting the top 10 sales of common drugs and
antibiotics. In addition, the top-selling antibiotics were
eliminated quarterly to effectively strengthen hospital
infection control and to resist illegal promotion of
pharmaceutical suppliers. Pharmacists underwent regular
professional training to improve their ability to handle
possible problems and to foster timely cooperation with
clinicians. Moreover, irrational drug use prescriptions

were registered, summarized, and analyzed to prevent
similar incidents, improve drug use levels, and minimize
the occurrence of irrational drug use.
Workflow was optimized by adding a prescription
review function by pharmacists to the HIS. Full-time
clinical pharmacists in the Pharmacy Department were
utilized to review the prescriptions issued by clinicians,
whereas the dispensing pharmacists were only in charge
of dispensing drugs and guiding administration. As a
result, prescription review pharmacists and dispensing
pharmacists became more specialized, which increased
the efficiency of the former and reduced the workload of
the latter, significantly reducing irrational drug use.
A standard operation procedure was developed
to standardize and systematize drug use guidance.
Meanwhile, each dug was tagged with the usage and
dosage, and special notices.
The working effect was added to the performance
appraisal system to investigate the patients. The mark rate
and the accuracy of drug usage, dosage, and notice were
incorporated. Various forms of publicity and education
concerning rational drug use were carried out. Frequently
asked questions were summarized and then printed in
brochures, which were distributed to patients for free.
Pharmacists initially exchanged contact details with
chronically ill, elderly, and combination therapy patients
in order to provide consultation at any time. The patients
were contacted regularly to assess the drug use situation
and provide guidance accordingly (22).
2.2.5. Control
Based on the improve stage, this stage emphasizes the
development of control measures by the Department of
Pharmacy to coordinate with other relevant departments
in order to evaluate the improvement effects, and to
summarize and solve possible problems in time to ensure
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a smooth workflow. The Department of Pharmacy
developed different satisfaction questionnaires for patients,
clinicians, and nurses to determine the satisfaction and
needs of the customers (clinicians, nurses, and patients)
concerning pharmaceutical care, and to further remedy
the emerging defects (23). Management staff, clinicians,
pharmacists, and nurses should attend seminars regularly
in order to communicate mutually and eventually improve
the rational use levels of medications.
3. Results
The control stage lasted for 6 months until basic stability
was achieved. Every month from July to December in
2011, 500 prescriptions were randomly selected in each
hospital. The total number of prescriptions was 17,049,
which covered all departments in the hospitals. The drug
use conditions in the prescriptions were investigated, and
the defect rate was 4.46%, which was 4.11% lower than
the rate prior to the intervention (Table 2). The Z value
was 3.01, an increase of 0.19 compared to that before the
intervention. On the t-test, P < 0.01.
4. Discussion
As a special service agency, the hospital plays a direct role
in human health that is in need of much higher quality
standards than other fields (24). The medical service has
also transformed to the mode that centralizes quality
management from the needs to the satisfaction of patients,
which determines the profit and development of hospitals.
Owing to the continuous development of medical science
and technology, more specialized third divisions, more
examination techniques, accelerated daily life, and
increased outpatients, it is imperative to improve valueadded service quality and patient satisfaction, significantly
reduce the limitation time on people, goods, and
equipment, and job switching time, simplify non-value–
added behaviors and processes in inventory, and eventually
lower operating costs. Therefore, hospital administrators
should introduce excellent enterprise management
methods to increase comprehensive competitiveness (25).
Six Sigma (6σ) is a target indicating that 99,999.96%
of all processes and results are defect-free. In other words,
only 4 things are allowed to be defective out of 1,000,000
things performed. As a quality management concept, Six

Sigma was first proposed by Bill Smith in Motorola in 1986.
This method has been verified to be effective in numerous
transnational corporations such as General Electric, Dell,
HP, Siemens, and Sony. After being introduced in China
in the late 1990s, the Six Sigma management method was
initially applied to manufacturing and logistics, which
began to be used in hospital management after 1999
(26,27).
Six Sigma management essentially consists of a
process improvement model, DMAIC: define, measure,
analyze, improve, and control. This method focuses
on customer needs, depends greatly on statistical data,
emphasizes the improvement of workflow, carries out
initiative management, and encourages enterprise
culture characteristics such as cooperation without
boundaries and diligent learning (28,29). In addition, this
method is advantageous in terms of enhanced enterprise
management, economized operating costs, elevated
customer value, improved service levels, and positive
enterprise culture.
Applying the Six Sigma management concept to the
clinical use of antibiotics in order to improve the rational
drug use level and guarantee medical safety is a long-term
task that is in need of constantly improved management
and working systems along with working methods. With
the further development of a specific rectification program
for antibiotics in China, the corresponding clinical use
management of antibiotics and other related systems
is gradually being established and improved (30). As a
result, clinical use management of antibiotics is gradually
becoming institutionalized and standardized, and the
resulting long-term working mechanism will be able to
promote the continuous improvement of antibiotics in
clinical application (31).
We applied advanced Six Sigma management in
order to intervene in clinical drug use via pharmacists,
cultivate administrators, doctors, nurses, and staff in
pharmacies and drug stores, optimize hospital processes,
and ultimately improve service quality. However,
irrational drug use is a comprehensive issue related to
concept, habit, technology, and management, leading to
the involvement of government agencies, health sectors,
drug administration sectors, pharmaceutical sales sectors,
news agencies, and hospital management sectors, and not
merely clinicians, pharmacists, nurses, and patients.
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